898 Awareness Regarding the Use of Topical Vancomycin in Cranial and Spinal Surgeries in Developing Countries

Abstract

Abstract Introduction Surgical site infections (SSI’s) remain a worrisome complication of any procedure requiring invasive intervention, consequences varying from suture abscesses to sepsis. Topical vancomycin administration has become popular in developed countries for SSI prevention, subsequent publications, and clinical experience supporting the practice as an effective strategy against SSI development. Yet, little information is available regarding the current practices and awareness of surgeons working in developing countries topically applying vancomycin for SSI prevention. Method An online anonymous validated survey comprising a structured questionnaire targeted at gaining an insight into current surgical practice and awareness in developing countries regarding topical administration of vancomycin for SSI prevention was conducted. Results 243 responses were recorded, with respondents from publicly and privately funded institutions evenly distributed. Increased awareness concerning topical administration of vancomycin was apparent amongst orthopaedic surgeons compared to neurosurgeons (p-value = 0.59) and South American respondents compared to Asia and Africa (p-value = 0.04). No difference in topical vancomycin usage awareness was found as per annual number of surgeries performed or respondents’ experience. Neurosurgeons administered topical vancomycin less frequently than orthopaedic respondents (p-value = 0.014), most frequent usage found in South America compared to Africa, which had the least (p-value = 0.051). Neurosurgeon respondents obtained information regarding topical vancomycin administration during residency, while orthopaedic respondents from journal articles. Conclusions 75% of respondents were aware topical vancomycin administration led to postoperative SSI risk reduction. Neurosurgeons were less familiar than orthopaedic surgeons, with South American respondents more likely to administer topical vancomycin than respondents practicing in other continents.